ArticleInvestigative ophthalmology & visual science2026
Genomic Copy Number Variants Associated With Strabismus and Amblyopia in the All of Us Research Program.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Amblyopia and adult health: a comprehensive analysis of long-term systemic, sensory and mental health comorbidities in a national cohort.The British journal of ophthalmology · 2026Article
- Case Report: From imaging to genetics: a case of congenital restrictive strabismus with SEOM expands the 22q11.2 duplication syndrome phenotype.Frontiers in medicine · 2026Article
Corrections and comments
- Update of
Authors and funding
2 authors.
Funding
Abstract
Purpose: To identify rare and common copy number variants (CNVs) associated with strabismus and amblyopia. Methods: Case-control association study using structural variant calls from short-read whole-genome sequencing from the All of Us Research Program, including 1224 adults with strabismus, 564 with amblyopia (152 with both), and controls (95,175 for strabismus; 95,319 for amblyopia). Autosomal CNVs were identified using the GATK-SV pipeline. After instituting quality control measures, CNVs present in ≥20 affected individuals were divided into rare (<1% population frequency) and common (>1% population frequency). CNVs were manually verified in Integrative Genomics Viewer. In an independent analysis, we examined three intergenic duplications previously associated with strabismus to assess whether the findings could be replicated. Results: One rare and three common CNVs were associated with amblyopia: a rare intronic deletion in MDGA2, an intronic duplication in CAMK2D, and intronic deletions in COG1 and KMT2C. Three rare and 2 common CNVs were associated with strabismus: rare intronic deletions in PCDH15, GTF2H1, and NKAIN3, a common intronic deletion in TRANK1, and a common intronic duplication in GRK5. Implicated genes predominantly affect neuronal and synaptic function, including modulation of postsynaptic potential, retrograde transport, glutaminergic synaptic transmission, and calcium-mediated signaling. GRK5 interacts with CXCR4, a chemokine receptor critical for axon guidance of the oculomotor nerve. The previously identified chr4 duplication was also significantly associated with strabismus in the AoURP dataset, replicating previous findings. Conclusions: CNVs are an additional source of genetic risk for strabismus and amblyopia and highlight synaptic and neurodevelopmental pathways as central to etiology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.